176 related articles for article (PubMed ID: 32282051)
1. An Activating Deletion Variant in the Submembrane Region of Natriuretic Peptide Receptor-B Causes Tall Stature.
Lauffer P; Miranda-Laferte E; van Duyvenvoorde HA; van Haeringen A; Werner F; Boudin E; Schmidt H; Mueller TD; Kuhn M; van der Kaay DCM
J Clin Endocrinol Metab; 2020 Jul; 105(7):2354-66. PubMed ID: 32282051
[TBL] [Abstract][Full Text] [Related]
2. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
[TBL] [Abstract][Full Text] [Related]
3. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Miura K; Namba N; Fujiwara M; Ohata Y; Ishida H; Kitaoka T; Kubota T; Hirai H; Higuchi C; Tsumaki N; Yoshikawa H; Sakai N; Michigami T; Ozono K
PLoS One; 2012; 7(8):e42180. PubMed ID: 22870295
[TBL] [Abstract][Full Text] [Related]
4. Broadening the Spectrum of Loss-of-Function Variants in NPR-C-Related Extreme Tall Stature.
Lauffer P; Boudin E; van der Kaay DCM; Koene S; van Haeringen A; van Tellingen V; Van Hul W; Prickett TCR; Mortier G; Espiner EA; van Duyvenvoorde HA
J Endocr Soc; 2022 Apr; 6(4):bvac019. PubMed ID: 35233476
[TBL] [Abstract][Full Text] [Related]
5. Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Miura K; Kim OH; Lee HR; Namba N; Michigami T; Yoo WJ; Choi IH; Ozono K; Cho TJ
Am J Med Genet A; 2014 Jan; 164A(1):156-63. PubMed ID: 24259409
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
Vasques GA; Amano N; Docko AJ; Funari MF; Quedas EP; Nishi MY; Arnhold IJ; Hasegawa T; Jorge AA
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1636-44. PubMed ID: 24001744
[TBL] [Abstract][Full Text] [Related]
7. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
9. Role of the natriuretic peptide system in normal growth and growth disorders.
Vasques GA; Arnhold IJ; Jorge AA
Horm Res Paediatr; 2014; 82(4):222-9. PubMed ID: 25196103
[TBL] [Abstract][Full Text] [Related]
10. Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations.
Hwang IT; Mizuno Y; Amano N; Lee HJ; Shim YS; Nam HK; Rhie YJ; Yang S; Lee KH; Hasegawa T; Kang MJ
Mol Genet Genomic Med; 2020 Mar; 8(3):e1146. PubMed ID: 31960617
[TBL] [Abstract][Full Text] [Related]
11. A new family with epiphyseal chondrodysplasia type Miura.
Kenis V; Melchenko E; Mazunin I; Pekkinen M; Mäkitie O
Am J Med Genet A; 2021 Jan; 185(1):112-118. PubMed ID: 33073519
[TBL] [Abstract][Full Text] [Related]
12. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
Thibault G; Grove KL; Deschepper CF
Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal tract disorder in natriuretic peptide receptor B gene mutant mice.
Sogawa C; Abe A; Tsuji T; Koizumi M; Saga T; Kunieda T
Am J Pathol; 2010 Aug; 177(2):822-8. PubMed ID: 20616347
[TBL] [Abstract][Full Text] [Related]
14. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.
Langenickel TH; Buttgereit J; Pagel-Langenickel I; Lindner M; Monti J; Beuerlein K; Al-Saadi N; Plehm R; Popova E; Tank J; Dietz R; Willenbrock R; Bader M
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4735-40. PubMed ID: 16537417
[TBL] [Abstract][Full Text] [Related]
15. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.
Yoder AR; Kruse AC; Earhart CA; Ohlendorf DH; Potter LR
Peptides; 2008 Sep; 29(9):1575-81. PubMed ID: 18554750
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
17. CNP-induced changes in pHi, cGMP/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells.
Zhong L; Chu E; Chu J; Chu TC
J Ocul Pharmacol Ther; 2003 Oct; 19(5):425-36. PubMed ID: 14583135
[TBL] [Abstract][Full Text] [Related]
18. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
19. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
Dickey DM; Otto NM; Potter LR
J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
[TBL] [Abstract][Full Text] [Related]
20.
Yuan K; Chen J; Chen Q; Chen H; Zhu J; Fang Y; Wang C
J Pediatr Endocrinol Metab; 2022 Feb; 35(2):185-190. PubMed ID: 34565054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
